RPRoyalty Pharma RPRX · NASDAQ
$62.15 -0.16% (-$0.10)
- Market cap
- $27.7B
- Enterprise value
- $35.8B
- P/E
- 33.9x
- Forward P/E
- -
- PEG
- -
- P/S
- 10.9x
- P/FCF
- 9.3x
- EV/EBITDA
- 20.9x
- ROIC
- 8.1%
- Bruto marža
- 89.4%
- Neto marža
- 32.1%
- Dividend yield
- 1.49%
- Payout ratio
- 50.5%
- Neto dolg/EBITDA
- 4.7x
- Beta
- 0.41
- Free float
- 93.7%
O podjetju
Royalty Pharma plc is an international pharmaceutical company based in New York, USA, specializing in investments in royalty and licensing rights to pharmaceutical products. The company focuses on providing financial resources to research and development pharmaceutical companies in exchange for rights to profits from the sale of their drugs.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Pablo Legorreta
Employees
100
Headquarters
New York
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke